RT @celltherapynews: #Hepatic Intra-Arterial Delivery of a “Trojan-Horses” #GeneTherapy @Inserm_EN https://t.co/5uI6nL7zq1
RT @CVIR_Journal: January's "Editor's Choice": Interesting laboratory investigation describing the intra-arterial use of genetically modifi…
RT @CVIR_Journal: January's "Editor's Choice": Interesting laboratory investigation describing the intra-arterial use of genetically modifi…
January's "Editor's Choice": Interesting laboratory investigation describing the intra-arterial use of genetically modified mesenchymal stem cells in combination with cyclophosphamide in rabbits with VX2 tumors. https://t.co/Jc7K4OgbOY @UParisDescartes @US
RT @celltherapynews: #Hepatic Intra-Arterial Delivery of a “Trojan-Horses” #GeneTherapy @Inserm_EN https://t.co/5uI6nL7zq1
RT @celltherapynews: #Hepatic Intra-Arterial Delivery of a “Trojan-Horses” #GeneTherapy @Inserm_EN https://t.co/5uI6nL7zq1
RT @celltherapynews: #Hepatic Intra-Arterial Delivery of a “Trojan-Horses” #GeneTherapy @Inserm_EN https://t.co/5uI6nL7zq1
#Hepatic Intra-Arterial Delivery of a “Trojan-Horses” #GeneTherapy @Inserm_EN https://t.co/5uI6nL7zq1